Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Probable adapter protein involved in signaling pathways. Additionally we are shipping Target of Myb1 (Chicken)-Like 1 Proteins (6) and and many more products for this protein.
Showing 10 out of 88 products:
Human Polyclonal TOM1L1 Primary Antibody for ELISA, WB - ABIN314348
Pulitzer, Li, Hanson, Singh, Elenitsas, Gelfand, VanVoorhees, Seykora: Srcasm overexpression in psoriasis-insights into pathogenesis. in Journal of cutaneous pathology 2007
TOM1L1 enhances ERBB2 (show ERBB2 Antibodies)-induced cell invasiveness by promoting invadopodia formation and MT1-MMP (show MMP14 Antibodies) trafficking to the plasma membrane.
whereas TOM1L1 depletion only slightly affected SRC (show SRC Antibodies)-induced proliferation of colorectal cancer cells in vitro, it drastically decreased tumor growth in xenografted nude mice.
This pattern of Srcasm expression suggests that it may act as a negative regulator in esophageal squamous cell carcinoma cell signaling
results imply that TOM1L has a mitogenic effect in Jurkat T-cells and is involved in a novel cell signaling pathway that is crucial for the IL-2 (show IL2 Antibodies) production and STAT3 (show STAT3 Antibodies) expression
Srcasm plays a role in linking EGF receptor (show EGFR Antibodies)- and SFK-dependent signaling to differentiation in keratinocytes
Tom1L1 could act as an intermediary between signaling and degradative pathways.
study found that not only the PTAP sequence in the GAT (show GLYAT Antibodies) domain but also the PSAP (show PSAP Antibodies) sequence in the C-terminal region of Tom1L1 is responsible for its interaction with the UEV domain of Tsg101 (show TSG101 Antibodies) and competes with the HIV-1 Gag protein for the Tsg101 (show TSG101 Antibodies) interaction
All multicentric and nodular basal cell carcinomas displayed a prominent loss of Srcasm staining in association with a marked increase in Ki-67 (show MKI67 Antibodies) staining.
Participation of Tom1L1 in EGF (show EGF Antibodies)-stimulated endocytosis of EGF receptor (show EGFR Antibodies).
Tom1L1 defines a novel mechanism for regulation of Src (show SRC Antibodies) family of protein-tyrosine kinases mitogenic signaling induced by growth factors.
Srcasm may act as a molecular "rheostat" for activated Src (show SRC Antibodies) family tyrosine kinases
Tom1L1-clathrin heavy chain (CHC (show CLTC Antibodies)) complex negatively regulates the level of SFK in caveolae needed for the induction of DNA synthesis.
Probable adapter protein involved in signaling pathways. Interacts with the SH2 and SH3 domains of various signaling proteins when it is phosphorylated. May promotes FYN activation, possibly by disrupting intramolecular SH3-dependent interactions (By similarity).
target of myb1-like 1
, target of myb1 (chicken)-like 1
, TOM1-like protein 1
, TOM1-like protein 1-like
, Src activating and signaling molecule
, src-activating and signaling molecule protein
, target of Myb-like protein 1
, target of myb 1-like 1
, Src-activating and signaling molecule protein
, Target of Myb-like protein 1
, Jerry protein